Anti CDK6 pAb (ATL-HPA002637 w/enhanced validation)

Catalog No:
ATL-HPA002637-25
$360.00
Application: WB, ICC, IHC 
Clonality: Polyclonal 
Host: Rabbit 
Reactivity: Human 
Protein Description: cyclin-dependent kinase 6
Gene Name: CDK6
Alternative Gene Name: PLSTIRE
Isotype: IgG
Interspecies mouse/rat: ENSMUSG00000040274: 92%, ENSRNOG00000009258: 92%
Entrez Gene ID: 1021
Uniprot ID: Q00534
Buffer: 40% glycerol and PBS (pH 7.2). 0.02% sodium azide is added as preservative.
Storage Temperature: Store at +4°C for short term storage. Long time storage is recommended at -20°C.

Cognate Antibody/Antigen for Anti CDK6 pAb (ATL-HPA002637 w/enhanced validation)
Antigen PrEST Antigen CDK6 (ATL-APrEST86426)
Documents & Links for Anti CDK6 pAb (ATL-HPA002637 w/enhanced validation)
Datasheet Anti CDK6 pAb (ATL-HPA002637 w/enhanced validation) Datasheet (External Link)
Vendor Page Anti CDK6 pAb (ATL-HPA002637 w/enhanced validation) at Atlas

Documents & Links for Anti CDK6 pAb (ATL-HPA002637 w/enhanced validation)
Datasheet Anti CDK6 pAb (ATL-HPA002637 w/enhanced validation) Datasheet (External Link)
Vendor Page Anti CDK6 pAb (ATL-HPA002637 w/enhanced validation)

Citations for Anti CDK6 pAb (ATL-HPA002637 w/enhanced validation) – 4 Found
Loss of the FAT1 Tumor Suppressor Promotes Resistance to CDK4/6 Inhibitors via the Hippo Pathway.
Cancer Cell. 2018 Dec 10;34(6):893-905.e8. doi: 10.1016/j.ccell.2018.11.006.  PubMed
The CDK4/6-EZH2 pathway is a potential therapeutic target for psoriasis.
J Clin Invest. 2020 Nov 2;130(11):5765-5781. doi: 10.1172/JCI134217.  PubMed
Requirement of DNMT1 to orchestrate epigenomic reprogramming for NPM-ALK-driven lymphomagenesis.
Life Sci Alliance. 2020 Dec 11;4(2):e202000794. doi: 10.26508/lsa.202000794. Print 2021 Feb.  PubMed
INK4 Tumor Suppressor Proteins Mediate Resistance to CDK4/6 Kinase Inhibitors.
Cancer Discov. 2022 Feb;12(2):356-371. doi: 10.1158/2159-8290.CD-20-1726. Epub 2021 Sep 20.  PubMed